Marker Therapeutics's market cap is currently $17.46M. The company's EPS TTM is $-1.081; its P/E ratio is ―; Marker Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 3.31M	$ 9.00M	$ 1.24M	$ 466.79K	$ 213.19K
Gross Profit	$ -7.11M	$ 5.32M	$ -1.92M	$ -18.41M	$ -12.55M
Operating Income	$ -14.58M	$ -29.95M	$ -39.48M	$ -28.89M	$ -22.53M
EBITDA	$ -11.79M	$ -19.79M	$ -36.32M	$ -27.63M	$ -22.03M
Net Income	$ -14.05M	$ -29.92M	$ -41.87M	$ -28.53M	$ -20.33M
Balance Sheet
Cash & Short-Term Investments	$ 15.11M	$ 11.78M	$ 42.35M	$ 21.35M	$ 43.90M
Total Assets	$ 17.13M	$ 34.42M	$ 68.14M	$ 45.61M	$ 46.36M
Total Debt	$ 0.00	$ 7.62M	$ 11.87M	$ 12.26M	$ 484.38K
Net Debt	$ -15.11M	$ -4.17M	$ -30.48M	$ -9.10M	$ -43.42M
Total Liabilities	$ 3.07M	$ 14.82M	$ 24.15M	$ 18.27M	$ 2.27M
Stockholders' Equity	$ 14.05M	$ 19.60M	$ 43.99M	$ 27.34M	$ 44.09M
Cash Flow
Free Cash Flow	$ -16.44M	$ -31.92M	$ -30.41M	$ -29.29M	$ -18.66M
Operating Cash Flow	$ -16.44M	$ -26.97M	$ -27.28M	$ -18.86M	$ -18.28M
Investing Cash Flow	$ 18.66M	$ -4.95M	$ -3.13M	$ -10.43M	$ -374.98K
Financing Cash Flow	$ 1.11M	$ 202.13K	$ 52.56M	$ 6.74M	$ 816.48K

Currency in USD

Marker Therapeutics Earnings and Revenue History

Income Statement >

Marker Therapeutics Debt to Assets

Balance Sheet >

Marker Therapeutics Cash Flow

Cash Flow >

Marker Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing